The underlying molecular mechanism is analogous to that employed by MALAT1 in NSCLC (Section 5: Lung cancer): SNHG5 directly binds miR-32 and in this way it reduces the inhibitory effects of miR-32 on KLF4 activity [82]. Here, KLF4 is linked to lung carcinoma.